Skip to main content
Sitaramesh Emani, MD, Cardiology, Cincinnati, OH

SitarameshEmaniMD(He/Him)

Cardiology Cincinnati, OH

Heart Failure & Transplantation, Interventional Cardiology

Director of Heart Failure Clinical Trials, The Christ Hospital Cincinnati, OH

Dr. Emani is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Emani's full profile

Already have an account?

  • Office

    2123 Auburn Ave
    Ste 138
    Cincinnati, OH 45219
    Phone+1 513-206-1180
    Fax+1 513-206-1182

Education & Training

  • Ohio State University Hospital
    Ohio State University HospitalFellowship, Advanced Heart Failure and Transplant Cardiology, 2012 - 2013
  • Ohio State University Hospital
    Ohio State University HospitalFellowship, Cardiovascular Disease, 2009 - 2012
  • Washington University/B-JH/SLCH Consortium
    Washington University/B-JH/SLCH ConsortiumResidency, Internal Medicine, 2006 - 2009
  • Ohio State University College of Medicine
    Ohio State University College of MedicineClass of 2006

Certifications & Licensure

  • OH State Medical License
    OH State Medical License 2009 - 2025
  • American Board of Internal Medicine Advanced Heart Failure and Transplant Cardiology
  • American Board of Internal Medicine Interventional Cardiology

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Anticoagulation Management Following Left Ventricular Assist Device Implantation Is Similar Across All Provider Strategies  
    Brent C Lampert, Sitaramesh Emani, Ahmet Kilic, Bryan A Whitson, Interactive CardioVascular and Thoracic Surgery

Press Mentions

  • Cincinnati Doctors Among First in Nation to Implant New Device to Treat Heart Failure
    Cincinnati Doctors Among First in Nation to Implant New Device to Treat Heart FailureJuly 23rd, 2024
  • FDA Approves Camzyos for the Treatment of Obstructive Hypertrophic Cardiomyopathy
    FDA Approves Camzyos for the Treatment of Obstructive Hypertrophic CardiomyopathyMay 6th, 2022
  • Why? Women More Likely to Die After Heart Attack Than Men – Study Finds
    Why? Women More Likely to Die After Heart Attack Than Men – Study FindsMarch 19th, 2022
  • Join now to see all

Professional Memberships